These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35165525)

  • 1. Potential Genes Associated with COVID-19 and Comorbidity.
    Feng S; Song F; Guo W; Tan J; Zhang X; Qiao F; Guo J; Zhang L; Jia X
    Int J Med Sci; 2022; 19(2):402-415. PubMed ID: 35165525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study.
    Íñiguez M; Pérez-Matute P; Villoslada-Blanco P; Recio-Fernandez E; Ezquerro-Pérez D; Alba J; Ferreira-Laso ML; Oteo JA
    Front Endocrinol (Lausanne); 2021; 12():688071. PubMed ID: 34489863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.
    Hasankhani A; Bahrami A; Sheybani N; Aria B; Hemati B; Fatehi F; Ghaem Maghami Farahani H; Javanmard G; Rezaee M; Kastelic JP; Barkema HW
    Front Immunol; 2021; 12():789317. PubMed ID: 34975885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental pollution and COVID-19: the molecular terms and predominant disease outcomes of their sweetheart agreement.
    Colacci A; Bortone G; Maffei G; Marchesi S; Mescoli A; Parmagnani F; Pillo G; Ranzi A; Rotondo F; Serra S; Vaccari M; Zauli Sajani S; Mascolo MG; Jacobs MN
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):169-182. PubMed ID: 33412808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into potential mechanisms of asthma patients with COVID-19: A study based on the gene expression profiling of bronchoalveolar lavage fluid.
    Jiang Y; Yan Q; Liu CX; Peng CW; Zheng WJ; Zhuang HF; Huang HT; Liu Q; Liao HL; Zhan SF; Liu XH; Huang XF
    Comput Biol Med; 2022 Jul; 146():105601. PubMed ID: 35751199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 induces "cytokine storm" hyperinflammatory responses in RA patients through pyroptosis.
    Zheng Q; Lin R; Chen Y; Lv Q; Zhang J; Zhai J; Xu W; Wang W
    Front Immunol; 2022; 13():1058884. PubMed ID: 36532040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFI44 is an immune evasion biomarker for SARS-CoV-2 and
    Zheng Q; Wang D; Lin R; Lv Q; Wang W
    Front Immunol; 2022; 13():1013322. PubMed ID: 36189314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mannose binding lectin gene 2 (rs1800450) missense variant may contribute to development and severity of COVID-19 infection.
    Medetalibeyoglu A; Bahat G; Senkal N; Kose M; Avci K; Sayin GY; Isoglu-Alkac U; Tukek T; Pehlivan S
    Infect Genet Evol; 2021 Apr; 89():104717. PubMed ID: 33515713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.
    Shah H; Khan MSH; Dhurandhar NV; Hegde V
    Acta Diabetol; 2021 Jul; 58(7):831-843. PubMed ID: 33587177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
    Zhang W; Yang Z; Zhou F; Wei Y; Ma X
    Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Genetic Predisposition Contribute to the Exacerbation of COVID-19 Symptoms in Individuals with Comorbidities and Explain the Huge Mortality Disparity between the East and the West?
    Yamamoto N; Yamamoto R; Ariumi Y; Mizokami M; Shimotohno K; Yoshikura H
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
    Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
    Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics and system biology approach to identify the influences of COVID-19 on cardiovascular and hypertensive comorbidities.
    Nashiry A; Sarmin Sumi S; Islam S; Quinn JMW; Moni MA
    Brief Bioinform; 2021 Mar; 22(2):1387-1401. PubMed ID: 33458761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.
    Islam MB; Chowdhury UN; Nain Z; Uddin S; Ahmed MB; Moni MA
    Comput Biol Med; 2021 Sep; 136():104668. PubMed ID: 34340124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of COVID-19 comorbidities reveals genes and pathways coincident with the SARS-CoV-2 viral disease.
    Dolan ME; Hill DP; Mukherjee G; McAndrews MS; Chesler EJ; Blake JA
    Sci Rep; 2020 Nov; 10(1):20848. PubMed ID: 33257774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploration and validation of related hub gene expression during SARS-CoV-2 infection of human bronchial organoids.
    Fang KY; Cao WC; Xie TA; Lv J; Chen JX; Cao XJ; Li ZW; Deng ST; Guo XG
    Hum Genomics; 2021 Mar; 15(1):18. PubMed ID: 33726831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Practical Strategy for Exploring the Pharmacological Mechanism of Luteolin Against COVID-19/Asthma Comorbidity: Findings of System Pharmacology and Bioinformatics Analysis.
    Xie YZ; Peng CW; Su ZQ; Huang HT; Liu XH; Zhan SF; Huang XF
    Front Immunol; 2021; 12():769011. PubMed ID: 35069542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACE2 Expression Is Increased in the Lungs of Patients With Comorbidities Associated With Severe COVID-19.
    Pinto BGG; Oliveira AER; Singh Y; Jimenez L; Gonçalves ANA; Ogava RLT; Creighton R; Schatzmann Peron JP; Nakaya HI
    J Infect Dis; 2020 Jul; 222(4):556-563. PubMed ID: 32526012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics Approaches to Identify the Comorbidity Complexities of SARS-CoV-2 Infection with Crohn's Disease.
    Li Y; Han X
    J Coll Physicians Surg Pak; 2023 Oct; 33(10):1093-1099. PubMed ID: 37804012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.